Rituximab can induce remission of nephrotic syndrome in the absence of peripheral B‐cells

E-ISSN： 1440-1797|20|9|667-668

ISSN： 1320-5358

Source： NEPHROLOGY, Vol.20, Iss.9, 2015-09, pp. : 667-668

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does ultraviolet B can induce programmed cell death in plant cells?

By Lytvyn D. Yemets A. Blume Y.

Radioprotection, Vol. 43, Iss. 5, 2008-09 ,pp. : 081-081

Edp Sciences

Access to resources Recommend Favorite

The Proportion of Regulatory T Cells in the Peripheral Blood Reflects the Relapse or Remission Status of Patients with Churg-Strauss Syndrome

International Archives of Allergy and Immunology, Vol. 155, Iss. 1, 2011-06 ,pp. : 46-52

Karger

Access to resources Recommend Favorite

Fatal rituximab‐associated lung injury syndrome in a patient treated with rituximab for recurrence of post‐transplant nephrotic syndrome

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 5, 2015-08 ,pp. : E115-E120

John Wiley & Sons Inc

Access to resources Recommend Favorite

BAFF augments IgA2 and IL‐10 production by TLR7/8 stimulated total peripheral blood B cells

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 48, Iss. 2, 2018-02 ,pp. : 283-292

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bone marrow stromal mesenchymal cells induce down regulation of CD20 expression on B‐CLL: implications for rituximab resistance in CLL

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 2, 2015-04 ,pp. : 211-218

John Wiley & Sons Inc

Access to resources Recommend Favorite